½ÃÀ庸°í¼­
»óǰÄÚµå
1441394

¼¼°è ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ±Ô¸ð,¿¹Ãø - ºÐ¼® À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Automated External Defibrillators Market Size study & Forecast, by Analysis Type, by End User and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ ¾à 8¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø±â°£(2023³â-2030³â) µ¿¾È 8.78%ÃʰúÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â´Â »ý¸íÀ» À§ÇùÇÏ´Â ºÎÁ¤¸Æ, ƯÈ÷ ½É½Ç¼¼µ¿À̳ª ½É½Ç ºó¹ÚÀ» ºÐ¼®,Ä¡·áÇϱâ À§Çؼ­ ¼³°èµÈ ÈÞ´ëÇü ÀüÀÚ ±â±âÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ »óÅ´ ½ÉÀåÀÇ Á¤»óÀûÀÎ ¸®µëÀÌ È寮·¯Á® Ç÷¾×À» È¿°úÀûÀ¸·Î Àü´ÞÇÒ ¼ö ¾ø°Ô µÇ´Â ÀÇ·á ±ä±Þ »óȲÀÎ °©ÀÛ½º·± ½ÉÁ¤Áö·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀåÀº ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷ÀÇ ±ÞÁõ µîÀÇ ¿äÀο¡ ÀÇÇØ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â´Â ÃÖ¼ÒÇÑÀÇ ÀÇ·á ÈÆ·ÃÀ¸·Î °³Àο¡¼­µµ »ç¿ëÇÒ ¼ö ÀÖ´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀåºñÀÔ´Ï´Ù. ½ÉÀå ¸®µëÀ» ºÐ¼®Çϰí Á¤»óÀûÀÎ ½ÉÀå ¹Úµ¿À» µÇã±â À§ÇØ Àü±â Ãæ°ÝÀÌ ÇÊ¿äÇÑÁö ¿©ºÎ¸¦ °áÁ¤ÇÏ´Â ¼¾¼­¸¦ °®Ãß°í ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ¼ö¿ä´Â 2023-2030³â ¿¹Ãø±â°£ µ¿¾È ±¹Á¦½ÃÀå¿¡¼­ Á¡Â÷ Áõ°¡ÇÒ Àü¸ÁÀÔ´Ï´Ù.

³ªÀ̰¡ µé¼ö·Ï ½ÉÇ÷°ü Àå¾Ö¿¡ ´ëÇÑ °¨¼ö¼ºÀÌ ³ô¾ÆÁö°í °©ÀÛ½º·± ½ÉÁ¤ÁöÀÇ À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. ÀÌ·¯ÇÑ »óȲ¿¡¼­´Â ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â°¡ ½Å¼ÓÇÑ °³ÀÔÀ» À§ÇØ ÇʼöÀûÀÔ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¼¼°è 60¼¼ ÀÌ»óÀÇ Àα¸´Â 2050³â±îÁö ¾à 21¾ï ¸íÀ¸·Î µÎ¹è·Î µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ 80¼¼ ÀÌ»óÀÇ Àα¸´Â 2020³â-2050³â »çÀÌ¿¡ 3¹è·Î Áõ°¡ÇÏ¿© 4¾ï 2,600¸¸¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ³ë·ÉÈ­´Â AEDÀÇ Á߿伺À» Áõ°¡½ÃŰ°í ´Ù¾çÇÑ °Ç°­ °ü¸® ÇöÀå¿¡¼­ÀÇ °¡¿ë¼º, ÀÎÁöµµ ¹× ±³À°ÀÇ Çʿ伺À» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀåÀ» °ßÀÎÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ ¿äÀÎÀº ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µé Áõ°¡ÀÔ´Ï´Ù. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡·Î °©ÀÛ½º·± ½ÉÁ¤Áö°¡ ¹ß»ýÇÒ °¡´É¼ºÀÌ ³ô¾ÆÁö°í, °á±¹ °ø°øÀå¼Ò, Á÷Àå, ÀÇ·á½Ã¼³ µî ´Ù¾çÇÑ Àå¸é¿¡¼­ ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ¼ö¿ä °¡ Áõ°¡Çß½À´Ï´Ù. ¶ÇÇÑ 2020³â ¹Ì±¹ ½ÉÀåÇùȸ°¡ ¹àÈù ¹Ù¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â °ü»óµ¿¸Æ¼º ½ÉÁúȯÀÌ ÁÖ¿ä ¿øÀÎÀ̸ç CVD °ü·Ã »ç¸Á·üÀÇ 41.2%¸¦ Â÷ÁöÇÑ ´ÙÀ½ ³úÁ¹ÁßÀÌ 17.3%, ±× ¹ÛÀÇ ½ÉÇ÷°ü ÁúȯÀÌ 16.8%, °íÇ÷¾ÐÀÌ 12.9%, ½ÉºÎÀüÀÌ 9.2%, µ¿¸Æ ÁúȯÀÌ 2.6%ÀÔ´Ï´Ù. ¶ÇÇÑ, ü¿Ü½Ä Á¦¼¼µ¿±âÀÇ ±â¼úÀû Áøº¸¿Í ½ÉÇ÷°ü ¼ö¼ú °Ç¼ö Áõ°¡°¡ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â¿Í °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ÀÎÁöµµ ºÎÁ·ÀÌ 2023³â-2030³âÀÇ ¿¹Ãø ±â°£À» ÅëÇØ ½ÃÀå ÀüüÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå Á¶»ç¿¡¼­ °í·ÁÇÑ ÁÖ¿ä Áö¿ª¿¡´Â ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«°¡ Æ÷ÇԵ˴ϴÙ. ºÏ¹Ì´Â ³ëÀÎ Àα¸ Áõ°¡, ½ÉÁ¤Áö·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö Áõ°¡, Á¦¼¼µ¿±â ±â¼ú Çâ»ó¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁü¿¡ µû¶ó 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. Á¦¼¼µ¿±âÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀº Àû½Ã¿¡ Á¤È®ÇÑ Á¦¼¼µ¿À» Á¦°øÇÏ´Â È¿°ú¿¡ ±â¿©ÇÕ´Ï´Ù. Çâ»óµÈ ¾Ë°í¸®Áò, »ç¿ëÀÚ ÀÎÅÍÆäÀ̽º ¹× Áø´Ü ±â´ÉÀº ºñ»ó½Ã ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±âÀÇ »ç¿ëÀ» ÃÖÀûÈ­ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ Áö¿ªÀÇ ¾ÐµµÀûÀÎ ½ÇÀûÀº ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±âÀÇ Àü¹ÝÀûÀÎ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ºÏ¹Ì´Â ÀÌ Áö¿ªÀÇ °Ç°­ °ü¸® »ê¾÷ È®´ë¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇコÄÉ¾î »ê¾÷Àº Á÷¿øÀÇ ÀÇ½Ä Çâ»ó°ú Æ®·¹ÀÌ´× ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÃßÁøÇÏ°í ½ÉÀåÀÇ ±ä±Þ »çÅ¿¡ ´ëÀÀÇÒ ¼ö Àִ ȯ°æÀ» Á¤µ·ÇÏ´Â ¿ªÇÒÀ» ÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¿©·¯ ºÎ¹®¿Í ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ¹àÈ÷°í ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡¿¡¼­ ¾÷°èÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î½ÃÀåÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ȯÀ² º¯È¯À²

Á¦3Àå ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå ¿ªÇÐ

  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀåÀÇ ¿µÇ⠺м®(2020³â-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • °í·ÉÀÚ Àα¸ Áõ°¡
      • ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µéÀÇ ±ÞÁõ
    • ½ÃÀåÀÇ °úÁ¦
      • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â¿¡ °ü·ÃµÈ °íºñ¿ë
      • ÀÎÁöµµÀÇ ºÎÁ·
    • ½ÃÀå ±âȸ
      • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±âÀÇ ±â¼úÀû Áøº¸
      • ½ÉÀåÇ÷°ü ¼ö¼ú Áõ°¡

Á¦4Àå ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±âÀÇ ½ÃÀå ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ºÐ¼® À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ºÐ¼® À¯Çüº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ºÐ¼® À¯Çüº°, ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¹ÝÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â
    • ÀüÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â

Á¦6Àå ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø/Áø·á¼Ò
    • ÀçÅÃÄ¡·á
    • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦7Àå ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå : Áö¿ª ºÐ¼®

  • ÁÖ¿ä±¹
  • ÁÖ¿ä ½ÅÈï±¹
  • ÀÚµ¿ ü¿Ü½Ä Á¦¼¼µ¿±â ½ÃÀå :Áö¿ª ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • ºÐ¼® À¯ÇüÀÇ ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
      • ÃÖÁ¾ »ç¿ëÀÚÀÇ ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Asahi Kasei Corporation
    • Stryker Corporation
    • Nihon Kohden Corporation
    • Koninklijke Philips NV
    • Mediana Co. Ltd
    • Schiller AG
    • Cardiac Science Corporation
    • Zoll Medical Corporation
    • Metrax GmbH
    • GE Healthcare

Á¦9Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
BJH 24.03.29

Global Automated External Defibrillators Market is valued at approximately USD 0.81 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.78 % during the forecast period 2023-2030. Automated External Defibrillators are portable electronic devices designed to analyze and treat life-threatening cardiac arrhythmias, specifically ventricular fibrillation and ventricular tachycardia. These conditions can lead to sudden cardiac arrest, a medical emergency where the heart's normal rhythm is disrupted, and it is unable to pump blood effectively. The Automated External Defibrillators Market is expanding because of factors such as the increasing number of aging populations and surge in the number of people suffering from cardiovascular diseases. Automated External Defibrillators are user-friendly devices that can be used by individuals with minimal medical training. They are equipped with sensors that analyze the heart's rhythm and determine if an electrical shock is necessary to restore a normal heartbeat. As a result, the demand for Automated External Defibrillators has progressively increased in the international market during the forecast period 2023-2030.

Individuals become increasingly sensitive to cardiovascular disorders as they age, which increases the risk of sudden cardiac arrest. In such situations, Automated External Defibrillators become critical for giving quick intervention. According to the World Health Organization, the world's population of persons aged 60 and more is anticipated to double approx. 2.1 billion by 2050. The number of people aged 80 and more is predicted to thrice between years 2020 and 2050, reaching 426 million. Furthermore, the aging population can amplify the importance of AEDs, prompting a need for increased availability, awareness, and training in various healthcare settings. Another important factor that drives the Automated External Defibrillators Market is the increasing number of people suffering from cardiovascular diseases. The growing prevalence of cardiovascular diseases led to increasing chances of sudden cardiac arrest events, which eventually created a greater demand for Automated External Defibrillators in various situations, including public places, workplaces, and healthcare facilities. In addition, in 2020, the American Heart Association revealed that in the United States, coronary heart disease was held accountable for the primary cause, responsible for 41.2% of CVD-related deaths, followed by stroke at 17.3%, other cardiovascular diseases at 16.8%, high blood pressure at 12.9%, heart failure at 9.2%, and diseases of the arteries at 2.6%. Moreover, technological advancements in external defibrillators devices and the increasing number of cardiovascular surgeries are anticipated to create lucrative growth opportunities for the market over the forecast period. However, the high cost associated with automated external defibrillators and lack of awareness is going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Automated External Defibrillators Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to growing geriatric population, increasing number of persons dying due to cardiac arrest, and rising emphasis on technological improvement in defibrillators in the region. Ongoing technological advancements in Defibrillators contribute to their effectiveness in delivering timely and accurate defibrillation. Enhanced algorithms, user interfaces, and diagnostic capabilities help optimize the use of Automated External Defibrillators in emergencies. The region's dominant performance is anticipated to propel the overall demand for Automated External Defibrillators. Furthermore, North America is expected to grow fastest over the forecast period, owing to factors such as the expansion of the healthcare industry in the region. The healthcare industry can play a role in promoting awareness and training initiatives among its workforce, creating a more prepared environment for responding to cardiac emergencies.

Major market player included in this report are:

  • Asahi Kasei Corporation
  • Stryker Corporation
  • Nihon Kohden Corporation
  • Koninklijke Philips NV
  • Mediana Co. Ltd
  • Schiller AG
  • Cardiac Science Corporation
  • Zoll Medical Corporation
  • Me¡©trax GmbH
  • GE Healthcare

Recent Developments in the Market:

  • In January 2023, Avive Solutions, Inc. got approval from the U.S. Food and Drug Administration (FDA), obtaining Pre-Market Approval (PMA) for its innovative Avive AED, an Automated External Defibrillator. This device has cellular, WiFi, GPS, and Bluetooth connectivity. Avive's breakthrough REALConnect Technology is powered by this connection package. It is intended to assist people access life-saving therapy when and where they need it by integrating with 911 centres through a partnership with RapidSOS. It also effortlessly communicates critical incident data to 911 dispatchers, EMS, and medical professionals at the appropriate time. REALConnect can also automate remote monitoring of Avive's AEDs to ensure proper maintenance and functionality.

Global Automated External Defibrillators Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Analysis Type, End User, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Analysis Type

  • Semi-automated External Defibrillators
  • Fully-automated External Defibrillators

By End User

  • Hospitals/Clinics
  • Home Care
  • Other End Users

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Automated External Defibrillators Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Automated External Defibrillators Market, by Analysis Type, 2020-2030 (USD Billion)
    • 1.2.3. Automated External Defibrillators Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Automated External Defibrillators Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Automated External Defibrillators Market Dynamics

  • 3.1. Automated External Defibrillators Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing number of aging populations
      • 3.1.1.2. Surge in number of people suffering from cardiovascular diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost associated with Automated External Defibrillators
      • 3.1.2.2. Lack of awareness
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in External Defibrillators devices
      • 3.1.3.2. Increasing number of cardiovascular surgeries

Chapter 4. Global Automated External Defibrillators Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Automated External Defibrillators Market, by Analysis Type

  • 5.1. Market Snapshot
  • 5.2. Global Automated External Defibrillators Market by Analysis Type, Performance - Potential Analysis
  • 5.3. Global Automated External Defibrillators Market Estimates & Forecasts by Analysis Type 2020-2030 (USD Billion)
  • 5.4. Automated External Defibrillators Market, Sub Segment Analysis
    • 5.4.1. Semi-automated External Defibrillators
    • 5.4.2. Fully-automated External Defibrillators

Chapter 6. Global Automated External Defibrillators Market, by End User

  • 6.1. Market Snapshot
  • 6.2. Global Automated External Defibrillators Market by End User, Performance - Potential Analysis
  • 6.3. Global Automated External Defibrillators Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 6.4. Automated External Defibrillators Market, Sub Segment Analysis
    • 6.4.1. Hospitals/Clinics
    • 6.4.2. Home Care
    • 6.4.3. Other End Users

Chapter 7. Global Automated External Defibrillators Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Automated External Defibrillators Market, Regional Market Snapshot
  • 7.4. North America Automated External Defibrillators Market
    • 7.4.1. U.S. Automated External Defibrillators Market
      • 7.4.1.1. Analysis Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Automated External Defibrillators Market
  • 7.5. Europe Automated External Defibrillators Market Snapshot
    • 7.5.1. U.K. Automated External Defibrillators Market
    • 7.5.2. Germany Automated External Defibrillators Market
    • 7.5.3. France Automated External Defibrillators Market
    • 7.5.4. Spain Automated External Defibrillators Market
    • 7.5.5. Italy Automated External Defibrillators Market
    • 7.5.6. Rest of Europe Automated External Defibrillators Market
  • 7.6. Asia-Pacific Automated External Defibrillators Market Snapshot
    • 7.6.1. China Automated External Defibrillators Market
    • 7.6.2. India Automated External Defibrillators Market
    • 7.6.3. Japan Automated External Defibrillators Market
    • 7.6.4. Australia Automated External Defibrillators Market
    • 7.6.5. South Korea Automated External Defibrillators Market
    • 7.6.6. Rest of Asia Pacific Automated External Defibrillators Market
  • 7.7. Latin America Automated External Defibrillators Market Snapshot
    • 7.7.1. Brazil Automated External Defibrillators Market
    • 7.7.2. Mexico Automated External Defibrillators Market
  • 7.8. Middle East & Africa Automated External Defibrillators Market
    • 7.8.1. Saudi Arabia Automated External Defibrillators Market
    • 7.8.2. South Africa Automated External Defibrillators Market
    • 7.8.3. Rest of Middle East & Africa Automated External Defibrillators Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Asahi Kasei Corporation
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Stryker Corporation
    • 8.3.3. Nihon Kohden Corporation
    • 8.3.4. Koninklijke Philips NV
    • 8.3.5. Mediana Co. Ltd
    • 8.3.6. Schiller AG
    • 8.3.7. Cardiac Science Corporation
    • 8.3.8. Zoll Medical Corporation
    • 8.3.9. Me¡©trax GmbH
    • 8.3.10. GE Healthcare

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦